Cas:243669-48-9 ethyl 2-amino-4-thiophen-2-ylthiophene-3-carboxylate manufacturer & supplier

Chemical Name:ethyl 2-amino-4-thiophen-2-ylthiophene-3-carboxylate

CAS.NO:243669-48-9

Synonyms:Ethyl 2-Amino-4-(2-thienyl)thiophene-3-carboxylate;2-Amino-3-ethoxycarbonyl-4-thienylthiophen;5′-Amino-[2,3′]bithiophenyl-4′-carboxylic acid ethyl ester;ethyl 5′-amino-2,3′-bithiophene-4′-carboxylate

Molecular Formula:C₁₁H₁₁NO₂S₂

Molecular Weight:253.34100

HS Code:2934999090

Physical and Chemical Properties:

Melting point:85ºC

Boiling point:389.3ºC at 760 mmHg

Density:1.33 g/cm3

Index of Refraction:

PSA:108.80000

Exact Mass:253.02300

LogP:3.81670

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Ethyl 2-Amino-4-(2-thienyl)thiophene-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 5′-amino-2,3′-bithiophene-4′-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-3-ethoxycarbonyl-4-thienylthiophen Use and application,Ethyl 2-Amino-4-(2-thienyl)thiophene-3-carboxylate technical grade,usp/ep/jp grade.

Related News: New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country. ethyl 2-amino-4-thiophen-2-ylthiophene-3-carboxylate manufacturer Separately, Europe’s drug regulator said on Friday that batches of J&J COVID-19 vaccine made for the region around the time the contamination issues were revealed at the Baltimore plant would, as a precaution, not be used. ethyl 2-amino-4-thiophen-2-ylthiophene-3-carboxylate supplier This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.? ethyl 2-amino-4-thiophen-2-ylthiophene-3-carboxylate vendor New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country. ethyl 2-amino-4-thiophen-2-ylthiophene-3-carboxylate factory Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.